MRSA

Devices & Diagnostics

Medtech company raises funds to help eliminate MRSA nasal colonization

Med Dev Corp., a Delaware-based startup, has raised $775,000 from private investors to reduce hospital-acquired infections or surgical-site infections. Med Dev’s devices all attempt a non-antibiotic approach to eradicating nasal MRSA colonization, which is “the No. 1 predictor” for SSIs in orthopedic, cardiac and GI surgeries, according to Chairman Mike Martin. The company still seeks […]

presented by